Labcorp added to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging.
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. This year, skip the clutter and gift pure ...
A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along with chemotherapy after surgery, according to a study appearing in JAMA ...
A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along with chemotherapy after surgery, according to new study in JAMA Oncology.
(NewsNation) — More than 150,000 cases of colorectal cancer are estimated to have been diagnosed in the United States this year, but the overall rate of colon or rectal cancer diagnoses have dropped ...
Don’t judge a kit by the box. I built six gingerbread house kits to find the best one on the market. Icing consistency and pouch shape played a big part in the ease of assembly and ability to ...
Colorectal cancer rates rose among younger adults; screening starts at 45. Blood-based tests like Shield offer less invasive detection to reach unscreened. Advocacy and education aim to expand access ...
Abbott made one of the biggest deals in recent medtech history last week when it announced its plan to acquire Exact Sciences — maker of colon cancer screening test Cologuard — for $23 billion.
Following a Dispatch investigation, the Ohio Department of Health temporarily ran out of free radon test kits from a surge in requests. The state has since restocked free test kits, which are ...
MONTGOMERY, Ala. (WSFA) - November is National Family Health History Month, and doctors say now is the time to get serious about colon cancer screenings. A new option is making the process easier and ...
Abbott is getting into cancer testing with its $21 billion acquisition Exact Sciences, the maker of the game-changing colorectal cancer test Cologuard. Abbott markets well-known diagnostics for ...
Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results